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Abstract
Motivation:
Algorithms for differential analysis of microarray data are vital to mod-
ern biomedical research. Their accuracy strongly depends on effective
treatment of inter-gene correlation. Correlation is ordinarily accounted
for in terms of its effect on significance cut-offs. In this paper it is shown
that correlation can, in fact, be exploited to share information across
tests, which, in turn, can increase statistical power.
Results:
Vastly and demonstrably improved differential analysis approaches are
the result of combining identifiability (the fact that in most microarray
data sets, a large proportion of genes can be identified a priori as non-
differential) with optimization criteria that incorporate correlation. As
a special case, we develop a method which builds upon the widely
used two-sample t-statistic based approach and uses the Mahalanobis
distance as an optimality criterion. Results on the prostate cancer data
of Singh et al. (2002) suggest that the proposed method outperforms
all published approaches in terms of statistical power.
Availability:
The proposed algorithm is implemented in MATLAB and in R. The
software, called Tellipsoid, and relevant data sets are available at www.
egr.msu.edu/~desaikey.
∗to whom correspondence should be addressed; contact: desaikey@egr.msu.edu
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1 Introduction
Detecting differentially expressed genes in the presence of substantial inter-
gene correlation is a challenging problem. Research has focused largely on
understanding the harmful effects of correlation on the threshold settings
demarcating null and non-null genes. In fact, however, the nominally con-
founding correlation can be exploited to increase statistical power of microar-
ray studies. This observation has engendered a fruitful research direction
introduced in this paper.
The literature is not devoid of attempts to develop more powerful sum-
mary statistics which exploit correlation, but such efforts have not produced
compelling results. We posit that the limitations of such developments are
due, at least in part, to neglecting identifiability – the fact that in most
microarray data sets, a large proportion of genes requires no technical effort
to be identified as explicitly non-differential.
In this paper, we present a new differential analysis method which ex-
ploits identifiability through an optimization criterion which incorporates
inter-gene correlation. The method builds upon the widely-used two-sample
t-statistic approach with a minimization of the Mahalanobis distance as the
optimality criterion. Although this paper focuses primarily on two-sample
microarray studies, the framework is readily generalizable for use in studies
with multiple or continuous covariates, as well as to other multiple compar-
ison applications.
Let us assume that m genes are measured on n microarrays, under two
different experimental conditions, such as control and treatment. Based
on the gene expression matrix X, we are interested in identifying a small
number of genes that are responsible for class distinction. One widely used
strategy [e.g., Tusher et al. (2001) and Efron (2004)] is to represent each
gene by its null hypothesis and two-sample t-statistic,1 say
Null hypotheses: H1, H2, . . . ,Hm
Test statistics: t1, t2, . . . , tm.
The magnitudes of the t-statistics establish a gene-ranking and the R
(presumably m) genes with the largest t-scores are reported as statisti-
cally significant discoveries. The investigator can either explicitly supply a
R or rely on the false discovery rate (FDR) calculations to find a maximal
R with the allowable FDR.
The issue of correctly estimating the FDR in the presence of correlation
has received much recent attention because highly correlated tests increase
the variance of the FDR leading to unreliable results (Owen, 2005). As
discussed in Efron (2007) and Desai et al. (2007), for “over powered” X’s,
there may be significantly fewer tail-area null counts than expected, while for
1null = non-differential; non-null = differential
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“under powered” X’s, the situation can worsen with many more tail-area
null counts than expected. Importantly though, techniques for correctly
estimating the FDR do not change the gene-ranking, but only the size of
the reported list.
The present research was motivated by the notion that, for “under pow-
ered” X’s, it might be possible to exploit correlation across ti’s to establish
a gene ranking that has better statistical power than the raw ti based rank-
ing. The method that resulted from an exploration of this question indeed
seems to improve the statistical power of all X’s. The proposed method
uses, (i) a vector of t-statistics (t = [t1, t2, . . . , tm]T ) and (ii) an estimate of
the covariance matrix of the vector t, to output a substantially revised ver-
sion of t, denoted u|t, whose corresponding entries can be used to establish
an improved gene-ranking.
The method is summarized as follows. Let2 t ∼ (u,Σ). Now based on
the measured value of t, we can estimate u|t, but while doing so we invoke
the zero assumption (ZA) (Efron, 2006) that the smallest P (%) of ti’s are
associated with null genes. Based on the ZA, we can set corresponding
entries of u to zero. For the remaining entries of u we obtain minimum
Mahalanobis distance (Mahalanobis, 1936) estimates.
Inter-gene correlation causes t to distribute around its center of mass
in an hyperellipsoidal manner, and the Mahalanobis distance is a natural
way to measure vector distances in such a distribution. In fact, the name
Tellipsoid is adopted to emphasize the geometric intuition of tracking the
center of an ellipsoid. We have done extensive experimentation with both
real and simulated data and found that for a truly null ti which happens to be
in tail-area, the corresponding ui|t consistently tends to zero (its theoretical
value).
Two prior research efforts were particularly useful in formulating the
present approach. Storey et al. (2007), present a more general approach
to the notion of sharing information across ti’s, which they describe as
“borrowing strength across the tests,” for a potential increase in statistical
power. Tibshirani and Wasserman (2006), discuss a new statistic called the
“correlation-shared” t-statistic, and derive theoretical bounds on its perfor-
mance; however, their approach requires strong assumptions regarding the
nature of correlation between null and non-null genes which may not hold
in many real data sets. The proposed method requires no such assumptions
and yet provides considerable increase in power as demonstrated by results
reported in Section 4.
The outline of this paper is as follows. Section 2 defines, and obtains
closed form expressions for, the minimum Mahalanobis distance estimates in
the t-statistic space. Section 3 builds on the theory of Section 2 to develop
the Tellipsoid gene-ranking method. In Section 4 we apply Tellipsoid to
2No distributional information nor higher order statistics of t are assumed.
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real cancer data of Singh et al. (2002) and compare its accuracy with the
state-of-the-art differential analysis tools EDGE (Storey et al., 2007) and
SAM (Tusher et al., 2001). Section 4 also discusses the implications of these
results. We conclude with Section 5 summarizing the main ideas.
2 Approach
2.1 Per gene summary statistic
Let X be the m×n matrix of gene expressions, for m genes and n samples.
We assume that the samples fall into two groups k = 1 and k = 2 and there
are nk samples in group k with n1 + n2 = n. We start with the standard
(unpaired) t-statistic:
ti =
x¯i;2 − x¯i;1
si
, (1)
where x¯i;k is the mean of gene i in group k and si is the pooled within-group
standard deviation of gene i. If the ith gene is indeed null, then we expect
ti ∼ (0, ν/(ν − 2)), where ν is the number of degrees of freedom, obtained
from either the unpaired t-test theory or the permutation null calculations
as in Efron (2007). If gene i is non-null, then we expect ti ∼ (ui, σ2i ). For
non-null genes, the values of ui and σi depend on the amount of up / down
regulation, the number of samples in each group, and ν.
2.2 The zero assumption
Without loss of generality, we may assume that the genes are indexed so
that
|t1| ≤ |t2| ≤ · · · ≤ |tm|. (2)
Then, a reasonable way to impose identifiability on null genes is through
the ZA, namely, that P (%) of the genes – those with the smallest t statis-
tics – are null. Efron (2006) discusses the use of the ZA in a variety of
differential analysis approaches. It plays a central role in the literature on
estimating the proportion of null genes, as in Pawitan et al. (2005) and
Langaas et al. (2005). The ZA is equally crucial for the two-group model
approach developed in the Bayesian microarray literature, as in Lee et al.
(2000), Newton et al. (2001), and Efron et al. (2001). Furthermore, the
claim that the method in Storey (2002) improves upon the well-known Ben-
jamini and Hochberg (1995) FDR procedure (in terms of statistical power)
also crucially relies on an adaptive version of the ZA. The use of the ZA is
justified in the present situation as long as P is sufficiently small so that the
bottom P (%) genes would almost certainly be declared null for reasonable
FDR’s.
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Formally, the ZA is stated as follows: Let c be the largest integer (gene
index) such that c/m ≤ P/100, denoted
c = d0.01mP e, (3)
then genes with indices 1, 2, . . . , c are assumed null. Let us partition the set
of t statistics into those corresponding to genes declared null under the ZA,
{t1, t2, . . . , tc}, and those for the remaining m − c genes which continue to
compete for the non-null designation, {tc+1, tc+2, . . . , tm}. For convenience,
we introduce the following vector notation,
t =
[
tT1:c t
T
c+1:m
]T
=
[
tT(0) t
T
(1)
]T
.
Then the random vector t is distributed in the following way:
t ∼ (u,Σ), (4)
where u is the underlying mean vector and Σ the covariance matrix. The
corresponding partitions of (u,Σ) are denoted
u =
(
u(0)
u(1)
)
and Σ =
(
Σ(00) Σ(01)
Σ(10) Σ(11)
)
.
The central hypothesis of this paper is that there is a vector, say u|t, whose
elements represent a reordering of the elements of the t, such that gene-
ranking represented by u|t has better statistical power for detecting non-null
genes than that based on t itself.
(In the present paper, we focus on mainly the second-moment distri-
butional characteristics of t. However, in fact, if the gene expressions are
normally distributed, then, perhaps, t is described more accurately by the
multivariate Student distribution. Exploitation of this additional structure
will be considered in future work.)
2.3 Estimating u|t
We are interested in obtaining an estimate of the vector mean u based on the
observation t. This requires an appropriate metric in the space of t vectors,
with which to quantify the distance of the observed t from the center of
mass u, say dist(t,u). The `2 norm induces a useful metric between t and
u provided that we first decorrelate the vector elements as Σ−1/2 (t− u),
thus yielding
dist(t,u) =
√
||Σ−1/2 (t− u) ||2
=
√
(t− u)TΣ−1(t− u). (5)
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This weighted Euclidean distance is sometimes called the Mahalanobis dis-
tance in the pattern classification literature as in Deller Jr et al. (1993),
Devijver and Kittler (1982), etc.
We can relate t to u through the Mahalanobis distance but while doing
so we invoke the ZA, which, in turn, implies that the first c entries of u are
zero. This yields the estimate
u∗ =
(
0
u∗(1)
)
, where u∗(1) = argmin
u(1)∈Rm−c
(6)
(
t(0) − 0
t(1) − u(1)
)T (Σ(00) Σ(01)
Σ(10) Σ(11)
)−1( t(0) − 0
t(1) − u(1)
)
.
In effect, u∗(1) combines the identifiability information based on the ZA with
the information about the covariance structure of t which too can be ob-
tained from the measured X itself. Notably the optimization in Eqn. (6)
enjoys closed form solution:
u∗(1) = t(1) −Σ(10)Σ−1(00)t(0). (7)
The derivation leading from Eqn. (6) to Eqn. (7) is provided in the Appendix.
2.4 Estimating Cov(ti, ti′)
To estimate the required entries of Σ, we make several observations. The va-
lidity of these observations can be established through computer simulations
using the MATLAB script testtcov.m available with the Tellipsoid software.
(Equation (7) does not require the covariance between two non-null ti’s.)
Observation 1. If genes i and i′ both are null, then
Cov(ti, ti′) ≈ Cor(xi, xi′) ν
ν − 2 (8)
Efron (2007) and Owen (2005) use this observation for their conditional FDR
calculations. This observation maybe intuitive to the reader from Eqn. (1)
itself, or it is easily verified through a computer simulation.
Observation 2. Similarly, if the gene i is null and i′ non-null (or con-
versely), then
Cov(ti, ti′) ≈
n2 Cor(xi;1, xi′;1) + n1 Cor(xi;2, xi′;2)
n1 + n2
ν
ν − 2 , (9)
where Cor(xi;k, xi′;k) denotes the correlation between gene i and i′ within
group k. Equation (9) accommodates the possibility that the correlation
between a null and a non-null gene may change across groups. If this does
not occur, then Eqn. (9) reduces to Eqn. (8).
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Observation 3. Furthermore, if n1 ≈ n2 (which is the case for most mi-
croarray studies), then Eqn. (9) simplifies to:
Cov(ti, ti′) ≈
Cor(xi;1, xi′;1) + Cor(xi;2, xi′;2)
2
ν
ν − 2 . (10)
Equations (8) and (10) suggest that we may use sample correlation to
estimate Cov(ti, ti′):
Ĉov(ti, ti′) ∝
∑
j x˜ij x˜i′j√(∑
j x˜
2
ij
)(∑
j x˜
2
i′j
) , (11)
where x˜ij denotes the expression level of the ith gene measured on the jth
microarray after subtracting the average response within each treatment
group. The scale factors cancel in the terms Σ(10) and Σ
−1
(00), so that esti-
mating ν/(ν-2) [see Eqn. (8)] is not required.
2.5 Tellipsoid equation
In light of Eqn. (11), Eqn. (7) takes the practical form
û∗(1) = t(1) − Ĉ(10)Ĉ−1(00)t(0), (12)
where Ĉ is the sample correlation matrix of the gene expression matrix
X˜ (after removing the treatment effects). In most cases computing the
full matrix inverse (Ĉ−1(00)) is not necessary and solving the term Ĉ
−1
(00)t(0)
through some efficient linear solver reduces the computation considerably.
(See Subsection 3.3 for detail).
3 Algorithm
3.1 Tellipsoid
This section outlines a self-contained differential analysis algorithm based on
the ideas discussed in Section 2. Its name Tellipsoid was coined to emphasize
the geometric intuition of tracking the center of an ellipsoid.
Tellipsoid takes gene expression matrix X and provides a specified num-
ber, R, of the most differentially expressed genes. In principle, the ranking
is based on the set {u∗i } from Eqn. (6). In practice, we rely on the estimates
{uˆ∗i } from Eqn. (12).
The algorithm begins by reindexing the genes based on their two-sample
t-statistics [Eqn. (2)]. Then, based on the ZA, the first c genes are identified
as null, as specified in Eqn. (3). By default, P is set to 50(%). Although the
choice 50% is somewhat arbitrary, this fraction has worked well empirically
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in the data sets tested. Future research may yield more rigorous methods
for choosing P .
In order to nullify any genuine treatment differences, X is converted
to X˜ by subtracting each genes average response within each treatment
group. The sample correlation matrix Ĉ of X˜ is computed subsequently.
The crucial step is to compute û∗(1) based on Eqn. (12). The elements of
û∗ = [0Tc×1 (û∗(1))
T ]T determine the gene-ranking: A gene with bigger |û∗i | is
assigned a higher rank. The first R genes are reported as top R statistical
discoveries.
3.2 Numerical stability
Because the number of samples n is often less than the number of genes
m, the sample correlation matrix turns out to be singular and hence non-
invertible. Therefore, we add a very small correction term (= 10−10) to its
diagonal entries to make it nonsingular, and in effect, invertible. After this
correction, Tellipsoid shows excellent numerical stability.
3.3 Computational complexity
Equation (12) involves matrix inversion, which, if performed in a naive way,
could be a prohibitive operation, since microarray data sets may have several
tens of thousand genes. Indeed, solving the term Ĉ−1(00)t(0) as a system of
simultaneous linear equations (Ĉ(00)x = t(0)) is much faster than explicitly
computing Ĉ−1(00). In particular, we can employ the Cholesky decomposi-
tion to exploit the fact that the matrix Ĉ(00) is symmetric and positive
definite. MATLAB implementation of Tellipsoid uses the in-built linslove
with appropriate settings, which, in turn, uses highly optimized routines of
LAPACK (Linear Algebra PACKage—http://www.netlib.org/lapack/).
For the Prostate data (used in Section 4) with 12625 genes and 102
samples, Tellipsoid, running on a computer with a 2.2 GHz dual-core AMD
Opteron processor with 8 GB of RAM and MATLAB version R2006b, re-
quires just under 40 seconds to report the final gene list. For the same
settings, the implementation with explicit matrix inversions takes ∼ 10 min-
utes.
3.4 Summary of Tellipsoid
Tellipsoid: An improved differential analysis algorithm
Input: X = Labeled m× n gene expression matrix; R = Size of gene list
Output: The gene list containing top R differentially expressed genes
1. Calculate two-sample (unpaired) t-statistics: ti = (x¯i;2 − x¯i;1)/si
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2. Reindex genes such that |t1| ≤ |t2| ≤ · · · ≤ |tm|
3. Gather first c = d0.01mP e ti’s in a vector t(0); By default P=50(%)
4. Convert X to X˜ by subtracting each genes average response within
each treatment group
5. Compute Ĉ = the sample correlation matrix of X˜
6. Find û∗ = [0Tc×1
(
û∗(1)
)T
]T , where û∗(1) = t(1) − Ĉ(10)Ĉ−1(00)t(0)
7. Determine gene-ranking: Assign a gene with bigger |û∗i | a higher rank
8. Report top R genes as statistical discoveries
4 Results and Discussion
We compare Tellipsoid with two of the leading techniques, SAM [Significance
Analysis of Microarrays (Tusher et al., 2001)] and EDGE [Extraction and
analysis of Differential Gene Expression (Leek et al., 2006)]. SAM adds a
small exchangeability factor s0 to the pooled sample variance when comput-
ing the two-sample t-statistic: di = (x¯i;2 − x¯i;1)/(si + s0); whereas EDGE
is based on a general framework for sharing information across tests (see
Storey et al. (2007)). EDGE is reported to show substantial improvement
(in terms of statistical power) over five of the leading techniques including
SAM (Storey et al., 2007). The other four are: (i) t/F–test of Kerr et al.
(2000) and Dudoit et al. (2002); (ii) Shrunken t/F–test of Cui et al. (2005);
(iii) The empirical Bayes local FDR of Efron et al. (2001); (iv) The a poste-
riori probability approach of Lonnstedt and Speed (2002). It is noteworthy
that Tellipsoid shows a major improvement over EDGE itself.
To determine the performance quality of various techniques, we focus
primarily on the empirical FDR in the reported gene list: Empirical FDR =
NoFP/R, where NoFP = the number of false positives. Broadly speaking,
smaller the FDR better the technique.
4.1 Prostate data
(Singh et al., 2002) studied m = 12625 genes on n = 102 oligonucleotide
microarrays, comparing n1 = 50 healthy males with n2 = 52 prostate cancer
patients. The purpose of their study was to identify genes that might an-
ticipate the clinical behavior of Prostate cancer. We downloaded the .CEL
files from http://www-genome.wi.mit.edu/MPR/prostate. The software
RMAExpress (Irizarry et al., 2003) was used to obtain high quality gene
expressions from these .CEL files. We let RMAExpress apply its in-built
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background adjustment, however, the quantile normalization was skipped.
Each gene was represented in the final expression matrix X by the loga-
rithm (base 10) of its expression level. Taking the log is thought to increase
normality and stabilize across group standard deviations (Tsai et al., 2003).
4.1.1 Data with known results
Algorithm testing required an expression matrix X with the knowledge of
truly non-differential genes. At the same time, we wanted the inter-gene
correlation in X to resemble that in the real microarray data. These two
seemingly conflicting requirements were satisfied concurrently by row stan-
dardizing a real X. The prostate cancer matrix X was transformed to X˜
by subtracting each gene’s average response within each treatment group,
and by normalizing within group sample mean squares. That is, for each
group k ∈ {1, 2}, (1/nk)
∑
j X˜ij = 0 and (1/nk)
∑
j X˜
2
ij = 1. Here, the
sum runs over corresponding nk samples only. With this transformation, all
genes have equal energy and yet the same within group inter-gene correlation
structure as the original X.3
To generate a test data set from X˜, its 102 columns were randomly di-
vided into groups of 50 (=n1) and 52 (=n2). Next mu (md) genes were
randomly chosen for up (down) regulation by adding a positive (negative)
offset xu (xd) to the corresponding entries in group 2. Various choices of
(mu,md, xu, xd) were tested to represent a range of differential analysis sce-
narios encountered in practice.
4.1.2 Results for prostate data
Two cases were studied. In the first, the proportion of truly differential
genes, say p1, was taken to be relatively small: p1 ∼ 0.01–0.05. The second
case employed a larger p1 ∼ 0.1. The former simulates microarray studies
seeking genes that distinguish subtypes of cancer, diabetes, etc., whereas
the latter resembles studies comparing healthy versus diseased cell activity.
Results were obtained using the subroutines samr.r from the package
“samr” and statex.r from the package “edge.” Both routines compute their
native gene summary statistics given the matrix X and corresponding col-
umn labels. These statistics, in turn, can be used to determine top R genes.
Case 1 [p1 ≈ 0.025, mu=200, md=100, xu=0.1, and xd=-0.1]. Figure 1(a)
shows plots of the FDRs for 40 different data sets with the size of the re-
ported list, R=300. A large value of R coincides with an attempt to extract
as many differential expressions as possible, a desired goal especially in mi-
croarray studies performed to identify genes that are to be explored further
3Note. Normalizing within group sample mean squares to unity is not implemented
in the Tellipsoid algorithm.
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– experimentally or computationally – to gain better understanding of un-
derlying gene networks. Since the differential signal xu=0.1 and xd=-0.1 is
rather weak, recovering a good list is not easy as evident from the results –
among all methods only Tellipsoid achieved sufficiently low FDRs to rescue
a few X’s.
0 10 20 30 400
0.5
1
FD
R
Data index
(a)
0 10 20 30 400
0.5
1
FD
R
Data index
(b)
Figure 1: FDRs for Case 1. The number of truly differential gene is 300.
Panel (a) R=300; Panel (b) R=100. Tellipsoid offers better detection.
Square () marker = Tellipsoid. Lines: solid = raw t-statistic; dotted =
SAM; dashed = EDGE.
Figure 1(b) presents results for R=100. A smaller R would be cho-
sen to identify high-quality class distinguishing features for gene-expression-
profiling-based clinical diagnosis and prognosis, where the goal is to build
accurate classifiers and predictors. Whereas Singh et al. (2002) build a clas-
sifier around only 16 of 12625 features, they do discuss the need to include as
many reliable features as possible. Remarkably, for 37 out of 40 X matrices,
Tellipsoid reports gene lists with no false discoveries at all, while the other
techniques fail to obtain a single gene list with an FDR<0.5.
Case 2a [p1 ≈ 0.1, mu=600, md=600, xu=0.02, and xd=-0.02]. In this set
of experiments, p1 is increased, but the differential signal is reduced. This
situation also proves to be challenging for the existing techniques. However,
Tellipsoid provides the FDR of ∼ 0.5 for R=1200, and, again for R=300,
while it reports most gene lists with no false discoveries at all.
Case 2b [p1 ≈0.1, mu=600, md=600, xu=0.1, and xd=-0.1]. This subcase
is designed to assess the effects of small sample sizes on performance. n1 and
n2 are both reduced to 20. We randomly chose 20 columns per group from
the original prostate cancer X, and then applied the data generation process
(including row standardization) detailed in Subsection 4.1.1. Reduction in
the number of samples is compensated by increase in the differential signal.
The FDRs for Tellipsoid, Fig. 3, are excellent suggesting that Tellipsoid
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Figure 2: FDRs for Case 2a. The number of truly differential gene is 1200.
Panel (a) R=1200; Panel (b) R=300. Tellipsoid performs much better.
Square () marker = Tellipsoid. Lines: solid = raw t-statistic; dotted =
SAM; dashed = EDGE.
increases power of small sample data sets too.
4.2 Simulated data
Before devising the test data setup of Subsection 4.1.1, Tellipsoid was tested
on several simulated data sets. Below we discuss some simulation results that
shed further light on the small sample behavior.
Let us denote by X(i) the ith column of a simulated expression matrix
X. We assume that the random vector X(i) is multivariate Gaussian with
mean 0 and covariance matrix W. Each such column represents m=3226
genes with a covariance matrix W that introduces roughly the same amount
of correlation as found in the BRCA data of Hedenfalk et al. (2001). We
choose mu = 50,md = 50, xu = 1, xd = −1, n1 = 10, and n2 = 10. Figure 4
shows plots of the FDRs for R=50 and R=100. Table 1 shows results for
some X realization from Fig. 4(b). Shown are the top 100 values of uˆ∗i
and each corresponding original ti with concomitant rank. With smaller n,
preeminence of Tellipsoid with respect to existing techniques scales down a
bit. Nevertheless, for R=50 case, for 25 out of 40 simulated X realizations,
Tellipsoid achieves a low FDR of ∼ 0.1 or less.
Interestingly, with a smaller n, SAM outperforms the other two tech-
niques. This is not entirely surprising as a smaller n can make the noise in
the per gene pooled variance si (and possibly the equivalent quantity in the
EDGE algorithm) more prominent. Nevertheless, SAM does mitigate this
issue in some measure by using the exchangeability factor s0 to adjust the
effective pooled variance (Tusher et al., 2001).
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1–50 51–100
uˆ∗i rank uˆ
∗
i ti ti rank uˆ
∗
i rank uˆ
∗
i ti ti rank
1 4.22 5.87 1 51 2.18 3.45 23
2 -4.17 -5.55 2 52 2.17 3.05 42
3 -3.93 -4.26 5 53 2.16 2.80 82
4 -3.74 -4.12 7 54 -2.15 -2.57 122
5 -3.58 -4.49 4 55 2.15 1.96 357
6 -3.49 -3.34 28 56 -2.14 -1.47 751
7 -3.45 -4.25 6 57 2.13 2.25 229
8 3.35 3.87 10 58 2.13 1.77 486
9 -3.33 -3.20 35 59 2.13 1.44 785
10 3.33 3.77 13 60 2.12 2.14 273
11 3.25 3.42 25 61 -2.11 -1.48 744
12 -3.16 -2.18 260 62 2.10 1.80 453
13 3.14 4.54 3 63 2.09 2.60 114
14 3.10 2.87 65 64 -2.09 -2.05 312
15 -3.08 -3.54 17 65 2.09 2.70 96
16 -3.07 -2.80 80 66 2.09 2.23 237
17 3.06 3.49 20 67 2.08 2.34 188
18 3.02 2.29 213 68 -2.08 -2.24 232
19 -2.99 -3.34 27 69 -2.06 -2.53 130
20 -2.93 -3.13 38 70 -2.04 -2.11 283
21 -2.92 -2.92 57 71 -2.04 -2.95 54
22 2.86 3.26 31 72 -2.03 -3.08 40
23 -2.83 -2.82 74 73 -2.02 -2.30 210
24 2.82 2.37 180 74 -2.01 -3.67 15
25 -2.81 -2.13 276 75 2.00 2.62 109
26 2.81 3.48 21 76 -1.98 -2.38 171
27 -2.79 -3.01 47 77 1.98 1.43 795
28 2.70 2.87 64 78 1.96 1.69 549
29 -2.66 -3.15 37 79 -1.95 -1.47 746
30 -2.58 -3.85 11 80 1.95 1.95 361
31 -2.56 -2.84 71 81 1.95 2.81 77
32 -2.55 -1.72 524 82 -1.94 -1.41 813
33 -2.54 -2.63 106 83 1.94 3.40 26
34 -2.54 -2.69 98 84 1.94 1.30 948
35 2.53 2.30 209 85 -1.94 -3.27 30
36 2.48 2.45 148 86 -1.93 -1.11 1190
37 -2.47 -2.29 212 87 -1.93 -1.37 872
38 -2.46 -3.21 33 88 -1.93 -3.44 24
39 -2.43 -2.44 154 89 -1.92 -3.07 41
40 2.43 2.71 94 90 -1.92 -1.50 726
41 2.40 2.86 66 91 1.90 3.62 16
42 -2.34 -2.60 115 92 -1.90 -2.82 75
43 -2.34 -2.98 50 93 1.89 1.25 1007
44 -2.33 -3.80 12 94 1.87 3.89 8
45 -2.32 -2.06 306 95 -1.86 -3.49 19
46 2.29 1.81 444 96 -1.86 -2.08 300
47 -2.27 -1.17 1110 97 1.85 1.20 1074
48 2.26 1.97 347 98 -1.83 -2.90 60
49 2.24 3.75 14 99 1.83 1.39 833
50 2.20 3.88 9 100 -1.82 -1.95 367
Table 1: Tellipsoid in action with Top 100 uˆ∗i ’s. Corresponding ti’s and their
rank are also shown. The results are for some X realization from Fig. 4(b).
Tellipsoid = 22 NoFPs; raw t-statistics = 68 NoFPs. Truly null genes are
printed in bold-sans typeface.
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Figure 3: FDRs for Case 2b. Panel (a) R=1200; Panel (b) R=300. The
sample size is smaller than that in Cases 1 & 2a and yet Tellipsoid performs
well. Square () marker = Tellipsoid. Lines: solid = raw t-statistic; dotted
= SAM; dashed = EDGE.
4.3 Discussion
By allowing researchers to examine the simultaneous expressions of enor-
mous numbers of genes, microarrays promised to revolutionize the under-
standing of complex diseases and usher in an era of personalized medicine.
However, the shift in perception of that promise is palpable in the literature.
A 1999 Nature Genetics article (Lander, 1999) is entitled “Array of hope,”
but a 2005 Nature Reviews article (Frantz, 2005) is entitled “An array of
problems.” It is not unusual for impacts of new technologies to be overes-
timated when first deployed, then to have the expectations moderated as
the technologies reveal new complexities in the problems they are designed
to solve. In the study of microarray data, the need for exceeding care in
the design and regularization of experiments and data collection are un-
derstood to be critical, but the biggest hindrance to progress has been the
data interpretation. In particular, as Efron (2007) and Owen (2005) point
out, the biggest challenge seems to be the treatment of intrinsic inter-gene
correlation.
In most microarray data there are at least three vital resources: (i)
identifiability (ii) immense parallel structure, and (iii) inter-gene correlation
itself. Thoughtful analyses in the papers by Efron (Efron, 2005, 2000) have
suggested this view of the rich information structure inherent in the data.
In this light, Tellipsoid can be viewed as exploiting more than correlation as
a means of sharing information across tests, as it also involves identifiability.
A crucial step in formulating Tellipsoid was the comprehension of the
effects of inter-gene correlation on Cov(ti, ti′). In light of Observations 1–3,
the choice of the Mahalanobis distance was intuitive, as it is already known
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Figure 4: FDRs for simulated data. Panel (a) R=100; Panel (b) R=50.
(Small) sample sizes: n1=10, n2=10. Yet, Tellipsoid performs better than
the rest. Square () marker = Tellipsoid. Lines: solid = raw t-statistic;
dotted = SAM; dashed = EDGE.
to give computationally attractive solutions through the matrix inversion
lemma.
Limited time and resources – and perhaps also the necessity for scientific
focus – often require biomedical researchers to work on only a small number
of “hot (gene) prospects.” Even under such highly conservative conditions,
however, misleading results can occur, as evident in the results of Figs. 1–4.
For all their careful development and statistical power, even state-of-the-
art tools like EDGE and SAM can report spurious gene lists. The extra
statistical power of Tellipsoid promises to further guard against anomalous
results that can have serious consequences for the trajectory of a study of
gene function, causation, and interaction.
5 Conclusion
This paper has reported the development and testing of a novel framework
for the detection of differential gene expression. The framework combines
the exploitation of inter-gene correlation to share information across tests,
with identifiability – the fact that in most microarray data sets, a large pro-
portion of genes can be identified a priori as non-differential. When applied
to the widely used two-sample t-statistic approach, this viewpoint yielded
an elegant differential analysis technique, Tellipsoid, which requires as in-
puts only a gene expression matrix, related two-sample labels, and the size
of desired gene-list R. Tellipsoid was tested on the prostate cancer data of
Singh et al. (2002) and some simulated data. Compared to SAM (Tusher
et al., 2001), EDGE (Storey et al., 2007), and the raw t-statistic approach it-
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self, Tellipsoid shows substantial improvement in statistical power. Usually,
with increase in microarray samples, power tends to increase considerably,
but, even for small sample sizes, Tellipsoid’s performance improvement is
noticeable. The software (coded in MATLAB and in R) and test data sets
are available at www.egr.msu.edu/~desaikey.
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APPENDIX
Suppose that
Σ−1 =
(
A B
C D
)
and u˜(1) = t(1) − u(1). (A-1)
We also have C = BT . Substituting these in Eqn. 6 yields:
u˜∗(1) = argmin
u˜(1)∈Rm−c
tT(0)At(0) + 2u˜
T
(1)Ct(0) + u˜
T
(1)Du˜(1). (A-2)
In Eqn. A-2, by setting the gradient w.r.t u˜(1) to 0, we obtain:
u˜∗(1) = −CTD−1t(0). (A-3)
Now for Σ−1, we can appeal to the matrix inversion lemma (Golub and
Van Loan, 1996):
Σ−1 =
(
Σ−1(00)
(
1 + Σ(01)Q−1Σ(10)Σ−1(00)
)
−Σ−1(00)Σ(01)Q−1
−Q−1Σ(10)Σ−1(00) Q−1
)
,
where Q = Σ(11) −Σ(10)Σ−1(00)Σ(01). Plugging this in Eqn. A-3 yields:
u˜∗(1) = Σ(10)Σ
−1
(00)t(0). (A-4)
Combining Eqn. A-4 with Eqn. A-1 provides the desired expression:
u∗(1) = t(1) −Σ(10)Σ−1(00)t(0) .
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